Identification of residues crucially involved in soluble guanylate cyclase activation

FEBS Letters

Volumn 580, Issue 17, 2006, Pages 4205-4213

  Rothkegel, Christiane ^a,b   Schmidt, Peter M ^c   Stoll, Friederike ^d   Schröder, Henning ^b   Schmidt, Harald H H W ^c   Stasch, Johannes Peter ^a  

^a Cardiovascular Research   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c MONASH UNIVERSITY   (Australia)

^d Bayer HealthCare   (Germany)

Author keywords

Bay 41 2272; BAY 58 2667; Cyclic GMP; Nitric oxide; Soluble guanylyl cyclase

Indexed keywords

ASPARTIC ACID; CYCLIC GMP; ENZYME ACTIVATOR; GUANYLATE CYCLASE; HEME; ISOLEUCINE; NITRIC OXIDE; OXYGEN; PHENYLALANINE; PROTEIN SUBUNIT; TYROSINE;

AMINO TERMINAL SEQUENCE; ARTICLE; CATALYSIS; CONFORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ANIMALS; CYCLIC GMP; ENZYME ACTIVATION; GUANYLATE CYCLASE; HEME; MODELS, MOLECULAR; PROTEIN STRUCTURE, TERTIARY; RATS; STRUCTURAL HOMOLOGY, PROTEIN; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY; THERMOANAEROBACTER;

EID: 33745949884     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.06.079     Document Type: Article

References (38)

1. Wedel B., Humbert P., Harteneck C., Foerster J., Malkewitz J., Böhme E., Schultz G., and Koesling D. Mutation of His-105 in the β1 subunit yields a nitric oxide-insensitive form of soluble guanylyl cyclase. Proc. Natl. Acad. Sci. USA 91 (1994) 2592-2596
2. Zhao Y., Schelvis J.P., Babcock G.T., and Marletta M.A. Identification of histidine 105 in the β-1 subunit of soluble guanylate cyclase as the heme proximal ligand. Biochemistry 37 (1998) 4502-4509
3. Schmidt P.M., Schramm M., Schröder H., Wunder F., and Stasch J.P. Identification of residues crucially involved in the binding of the heme moiety of soluble guanylyl cyclase. J. Biol. Chem. 279 (2004) 3025-3032
4. Schmidt P.M., Rothkegel C., Wunder F., Schröder H., and Stasch J.P. Residues stabilizing the heme moiety of the nitric oxide sensor soluble guanylate cyclase. Eur. J. Pharmacol. 513 (2005) 67-74
5. Pellicena P., Karow D.S., Boon E.S., Marletta M.A., and Kuriyan J. Crystal structure of an oxygen-binding heme domain related to soluble guanylate cyclase. Proc. Natl. Acad. Sci. USA 101 (2004) 12854-12859
6. Nioche P., Berka V., Vipond J., Minton N., Tsai A.L., and Raman C.S. Femtomolar sensivity of a NO sensor from Clostridium botulinum. Science 306 (2004) 1550-1553
7. Feil R., and Kemp-Harper B. cGMP signaling from bench to bedside. EMBO 7 (2006) 149-153
8. Hobbs A.J. Soluble guanylate cyclase: an old therapeutic target revisited. Br. J. Pharmacol. 136 (2002) 637-640
9. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43 (1991) 109-142
10. Ko F.N., Wu C.C., Kuo S.C., Lee F.Y., and Teng C.M. YC-1, a novel activator of platelet guanylate cyclase. Blood 84 (1994) 4226-4233
11. Stasch J.P., Becker E.M., Alonso-Alija C., Apeler H., Dembowsky K., Feurer A., Gerzer R., Minuth T., Perzborn E., Pleiss U., Schröder H., Schröder W., Stahl E., Steinke W., Straub A., and Schramm M. NO-independent regulatory site on soluble guanylate cyclase. Nature 410 (2001) 212-215
12. Stasch J.P., Alonso-Alija C., Apeler H., Dembowsky K., Feurer A., Minuth T., Perzborn E., Schramm M., and Straub A. Cardiovascular actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: in vitro studies. Br. J. Pharmacol. 135 (2002) 333-343
13. Stasch J.P., Schmidt P., Alonso-Alija C., Apeler H., Dembowsky K., Haerter M., Heil M., Minuth T., Perzborn E., Pleiss U., Schramm M., Schröder H., Schröder W., Stahl E., Steinke W., and Wunder F. NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle. Br. J. Pharmacol. 136 (2002) 773-783
14. Friebe A., Schultz G., and Koesling D. Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme. EMBO J. 15 (1996) 6863-6868
15. Schmidt P., Schramm M., Schröder H., and Stasch J.P. Mechanisms of nitric oxide independent activation of soluble guanylyl cyclase. Eur. J. Pharmacol. 468 (2003) 167-174
16. Wunder F., Stasch J.P., Hütter J., Alonso-Alija C., Hüser J., and Lohrmann E. A cell-based cGMP assay useful for ultra-high-throughput screening and identification of modulators of the NO/cGMP pathway. Anal. Biochem. 339 (2005) 104-112
17. Boon E.M., Huang S.H., and Marletta M.A. A molecular basis for NO selectivity in soluble guanylate cyclase. Nat. Chem. Biol. 1 (2005) 53-59
18. Alonso-Alija, C., Heil, M., Flubacher, D., Naab, P., Stasch, J.P., Wunder, F., Dembowsky, K., Perzborn, E. and Stahl, E. (2001) Novel derivates of dicarboxylicacid having pharmaceutical properties. WO-119780-A2001.03.22.
19. Straub A., Stasch J.P., Alonso-Alija C., Benet-Buchholz J., Ducke B., Feurer A., and Fürstner C. NO-independent stimulators of soluble guanylate cyclase. Bioorg. Med. Lett. 11 (2001) 781-784
20. Corpet F. Multiple sequence alignment with hierarchical clustering. Nucleic Acid Res. 16 (1988) 10881-10890
21. Gouet P., Courcelle E., Stuart D.I., and Metoz F. ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics 15 (1999) 305-308
22. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
23. Towbin H., Staehlin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76 (1979) 4350-4354
24. Becker E.M., Wunder F., Kast R., Robyr C., Hoenicka M., Gerzer R., Schröder H., and Stasch J.P. Generation and characterization of a stable soluble guanylate cyclase overexpressing CHO cell line. Nitric Oxide 3 (1999) 55-66
25. Zabel U., Weeger M., La M., and Schmidt H.H. Human soluble guanylate cyclase: functional expression and revised isoenzyme family. Biochem. J. 335 (1998) 51-57
26. Ballou D.P., Zhao Y., Brandish P.E., and Marletta M.A. Revisiting the kinetics of nitric oxide (NO) binding to soluble guanylate cyclase: the simple NO-binding model is incorrect. Proc. Natl. Acad. Sci. USA 99 (2002) 12097-12101
27. Bellamy T.C., Wood J., and Garthwaite J. On the activation of soluble guanylyl cyclase by nitric oxide. Proc. Natl. Acad. Sci. USA 99 (2001) 507-510
28. Negrerie M., Bouzhir L., Martin J.L., and Liebl U. Control of nitric oxide dynamics by guanylate cyclase in its activated state. J. Biol. Chem. 276 (2001) 46815-46821
29. Boon E.M., and Marletta M.A. Ligand discrimination in soluble guanylate cyclase and the H-NOX family of heme sensor proteins. Curr. Opin. Chem. Biol. 9 (2005) 441-446
30. Zhao Y., Brandish P.E., Ballou D.P., and Marletta M.A. A molecular basis for nitric oxide sensing by soluble guanylate cyclase. Proc. Natl. Acad. Sci. USA 96 (1999) 14753-14758
31. Olson J.S., and Phillips G.N. Kinetic pathways of barriers for ligand binding to myoglobin. J. Biol. Chem. 271 (1996) 17593-17596
32. Phillips G.N., Teodoro M.L., Li T.S., Smith B., and Olson J.S. Bound CO is a molecular probe of electrostatic potential in the distal pocket of myoglobin. J. Phys. Chem. B 103 (1999) 8817-8829
33. Spiro T.G., and Jarzecki A.A. Heme-based sensors: theoretical modeling of heme-ligand-protein interactions. Curr. Opin. Chem. Biol. 5 (2001) 715-723
34. Gong W., Hao B., and Chan M.K. New mechanistic insights from structural studies of the oxygen-sensing domain of Bradyrhizobium japonicum FixL. Biochemistry 39 (2000) 3955-3962
35. Jain R., and Chan M.K. Mechanisms of ligand discrimination by heme proteins. J. Biol. Inorg. Chem. 8 (2003) 1-11
36. Weber R.E., and Vinogradov S.N. Non vertebrate hemoglobins: functions and molecular adaptations. Physiol. Rev. 81 (2001) 569-628
37. Ignarro L.J., Ballot B., and Wood K.S. Regulation of soluble guanylate cyclase activity by porphyrins and metalloporphyrins. J. Biol. Chem. 259 (1984) 6201-6207
38. Hoenicka M., Becker E.M., Apeler H., Sirichoke T., Schröder H., Gerzer R., and Stasch J.P. Purified soluble guanylate cyclase expressed in a baculovirus Sf9 system: stimulation by YC-1, nitric oxide and carbon monoxide. J. Mol. Med. 77 (1999) 14-23